Evidence map›Paper›PMID 37448770›Full record

ArticleOne health (Amsterdam, Netherlands)2023

Expansion of healthcare-associated hypervirulent KPC-2-producing

Fernanda Esposito, Brenda Cardoso, Fábio P Sellera, Elder Sano, Danny Fuentes-Castillo, Herrison Fontana, Bruna Fuga, Quézia Moura, Maria I Z Sato, Carlos J Brandão and 1 more

Open access · goldAbstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Phylogenomic analysis of aquatic and clinical OXA-23-positiveOne health (Amsterdam, Netherlands) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Acute Exacerbation of Chronic Obstructive Pulmonary Disease Due to Carbapenem-ResistantInternational journal of chronic obstructive pulmonary disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Fernanda EspositoDepartment of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Brenda CardosoOne Health Brazilian Resistance Project (OneBR), Brazil.
Fábio P SelleraOne Health Brazilian Resistance Project (OneBR), Brazil.
Elder SanoOne Health Brazilian Resistance Project (OneBR), Brazil.
Danny Fuentes-CastilloOne Health Brazilian Resistance Project (OneBR), Brazil.
Herrison FontanaDepartment of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Bruna FugaDepartment of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Quézia MouraFederal Institute of Education Science and Technology of Espírito Santo, Vila Velha, Brazil.
Maria I Z SatoEnvironmental Company of São Paulo State (CETESB), São Paulo, Brazil.
Carlos J BrandãoEnvironmental Company of São Paulo State (CETESB), São Paulo, Brazil.
Nilton LincopanDepartment of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRCompanhia Energética de São Paulo · BRInstituto Federal do Espírito Santo · BRUniversity of Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of carbapenemase-producing

Indexed as

CarbapenemsEnterobacteralesEnvironmental disseminationGenomic surveillanceOne HealthResistomeVirulomeWHO critical priority pathogens

Identifiers

PMID37448770
PMCPMC10336671
OpenAlexW4382047078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.